Table 2 Characteristics of the rash and complications associated with MPX
Author | Rash (affected patients/total patients) | Lesions on mucous membranes (affected patients/total patients) | Number of lesions (affected patients/total patients) | Complications (affected patients/total patients) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Monomorphic | Pleomorphic | Rash site | Body Distribution | Ocular lesions | Secondary bacterial skin infection | Hemorrhagic pustules | Ulcerated or necrotic lesions | Deaths | Hospitalised patients | |||
Formenty et.al. | NR | NR | Entire Body: 8/11 Head and/or neck: 3/8 Arms and/or hands: 3/8 Legs and/or feets: 3/8 Chest and/or Abdomen: | NR | Oral cavity: 6/8 |  < 100: 3/6 > 100:3/6 | NR | NR | NR | NR | 0/19 | 7/19 |
Huhn et.al. | 21/31 | 9/31 | Entire Body: 7/31 Head or neck: 20/32 Arms or hands: 26/32 Pelvic area and groin: 3/32 Legs or feet: 21/32 Chest or Abdomen:18/32 | Centrifugal: 15/31 Centripetal:1/31 | Oral cavity: 7/34 |  < 100: 24/30 > 100: 6/30 | NR | 19/40 | 2/34 | 8/34 | 0/34 | 9/34 |
Yinka-Ogunleye et al. | 25/40 | 15/40 | Head and/or neck: 68/71 Arms and/or hands: 55/70 pelvic area and groin: 44/65 Legs and/or feets: 63/69 Chest and/or Abdomen:56/70 Palms: 48/70 Sole of the foot: 42/66 | NR | Genitals: 25/40 |  < 100: 16/40 > 100: 24/40 | NR | 19/40 | NR | NR | 7/122 | NR |
Whitehouse et al. | 286/319 | NR | Head and/or neck:1036/1057 Arms and/or hands: 1026/1057 Pelvic area and groin: 300/1057 Legs and/or feets: 786/1057 Chest and/or Abdomen:1028/1057 Palms: 1009/1057 v: 885/1057 | Centrifugal: 989/1025 Centripetal: 33/1025 | Oral cavity 570/1018 Genitals: 300/1057 |  < 100: 510/1043  > 100: 533/1043 | NR | NR | NR | NR | NR | NR |
Ježek et al. | 233/295 | 62/295 | Head and/or neck: 256/295 Palms: 206/295 Sole of the foot: 196/295 | Centrifugal: 245/295 Centripetal: 13/295 | Oral cavity: 207/295 Genitals: 88/295 Conjunctiva: 57/295 |  < 100: 77 /295  > 100: 218/295 | 11/295 | 48/295 | 0/295 | NR | 33/338 | NR |
Kalthan et.al | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 3/12 | 10/12 |
Pittman et al. | NR | NR | NR | NR | Oral cavity: 53/216 | NR | NR | 18/216 | 6/216 | NR | 3/216 | NR |
Breman et.al. | NR | NR | NR | NR | NR |  < 100: 24/47 > 100: 23/47 | 1/47 | NR | NR | NR | 8/47 | NR |
Perez-Duque | NR | NR | Pelvic area and groin: 6/27 | NR | Genitals: 6/27 | NR | NR | NR | NR | 11/27 | 0/27 | 3/27 |
Learned et.al. | NR | NR | NR | NR | NR |  < 100: 6/8 > 100:2/8 | 1/11 | NR | NR | NR | 0/11 | 8/11 |
Mande et al. | 18/21 | 3/21 | Arms and/or hands: 18/21 Sole of the foot:15/21 | NR | NR | NR | 8/21 | NR | NR | NR | NR | NR |
Girometti et.al. | NR | 48/54 | Head or neck: 11/54 Arms or hands: 11/54 Pelvic area and groin: 51/54 Legs or feet: 11/54 Chest or Abdomen: 14/54 | NR | Oral cavity:4/54 | NR | NR | 6/54 | NR | NR | NR | 5/54 |
Vaughan et al. | NR | NR | Pelvic area and groin: 1/2 | NR | Oral cavity: 1/2 | NR | NR | NR | NR | NR | NR | NR |
Antinori et al. | NR | NR | Head or neck: 1/4 Pelvic area and groin: 3/4 Legs or feet: 3/4 Chest or Abdomen: 2/4 Sole of the foot:1/4 | NR | Anal or rectal area: 2/4 | NR | NR | NR | NR | NR | NR | NR |
Hammerschlag et al. | NR | NR | Pelvic area and groin: 1/1 Head or neck: 1/1 Chest or Abdomen: 1/1 | NR | NR | NR | NR | NR | NR | NR | NR | NR |
De Nicolas-Ruanes et al. | NR | NR | Pelvic area and groin: 1/1 | NR | Anal or rectal area: 1/1 | NR | NR | NR | NR | 1/1 | NR | NR |
Erez et al. | NR | NR | Entire Body: 1/1 | NR | NR | NR | NR | NR | NR | 1/1 | NR | NR |
Adler et al. | NR | 7/7 | Head or neck:7/7 Arms or hands: 3/7 pelvic area and groin:4/7 Legs or feet: 1/7 Chest or Abdomen:7/7 Palm:4/7 Sole of the foot:2/7 | NR | NR | NR | NR | 0/7 | NR | 2/7 | 0/7 | 7/7 |